Following an inquiry into Community Diagnostic Centres (CDCs), the All-Party Parliamentary Group for Diagnostics has published its first report, highlighting the benefits of the programme, as well as its concerns. This article provides an overview of the report findings, highlights CDCs’ efforts to tackle the backlog, and looks at the role of investment in MedTech in driving efficiency.
As part of its inquiry into CDCs, the APPG for Diagnostics held two roundtables in June and July 2023 to investigate the current state and future of the programme. Chair and former health minister, Maggie Throup MP, led discussion with the support of the joint secretariat, The Royal College of Pathologists and The Royal College of Radiologists.
The report, CDCs Unveiled: Challenges & Triumphs; An Inquiry into Community Diagnostic Centres shows that NHS England and the government have made strides in delivering the CDC programme, approving 174 CDC sites and opening one in each Integrated Care System (ICS).1 However, concerns persist about unequal geographic distribution and funding constraints for future expansion.
CDCs are multi-diagnostic facilities created to bolster local diagnostic capacity; enhance patient access, experience and outcomes; alleviate hospital burden; and address regional disparities in healthcare. They provide a range of imaging, endoscopy, physiological science and pathology services.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
